These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10706954)

  • 61. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G
    Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
    Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
    J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Somatostatin enhances the chemosensitivity of GBC-SD cell line to doxorubicin through arresting the cell cycle to S phase rather than through the P53/Bax-depended apoptosis way in vitro.
    Songgang L; Jiyu L; Gongwei ; Yingbin L; Yiyu Q; Zhiwei Q
    Hepatogastroenterology; 2009; 56(94-95):1253-60. PubMed ID: 19950772
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.
    Ferone D; Pivonello R; Van Hagen PM; Dalm VA; Lichtenauer-Kaligis EG; Waaijers M; Van Koetsveld PM; Mooy DM; Colao A; Minuto F; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1056-66. PubMed ID: 12376335
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients.
    Reubi JC; Waser B; Cescato R; Gloor B; Stettler C; Christ E
    J Clin Endocrinol Metab; 2010 May; 95(5):2343-50. PubMed ID: 20228164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies.
    O'Toole D; Saveanu A; Couvelard A; Gunz G; Enjalbert A; Jaquet P; Ruszniewski P; Barlier A
    Eur J Endocrinol; 2006 Dec; 155(6):849-57. PubMed ID: 17132755
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Expression of Somatostatin Receptor Subtypes (SSTR-1-SSTR-5) in Pediatric Hematological and Oncological Disorders.
    Harda K; Szabo Z; Juhasz E; Dezso B; Kiss C; Schally AV; Halmos G
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33297556
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma.
    Georgantzi K; Tsolakis AV; Stridsberg M; Jakobson A; Christofferson R; Janson ET
    Pediatr Blood Cancer; 2011 Apr; 56(4):584-9. PubMed ID: 21298743
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
    Ferone D; Arvigo M; Semino C; Jaquet P; Saveanu A; Taylor JE; Moreau JP; Culler MD; Albertelli M; Minuto F; Barreca A
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1044-50. PubMed ID: 16046458
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Investigation of cancer cell lines for peptide receptor-targeted drug development.
    Sun L; Luo J; Mackey LV; Morris LM; Franko-Tobin LG; LePage KT; Coy DH
    J Drug Target; 2011 Sep; 19(8):719-30. PubMed ID: 21830941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of somatostatin receptor subtype 2 expression in stably transfected A-427 human cancer cells.
    Parry JJ; Eiblmaier M; Andrews R; Meyer LA; Higashikubo R; Anderson CJ; Rogers BE
    Mol Imaging; 2007; 6(1):56-67. PubMed ID: 17311765
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.
    Judware R; Culp LA
    Oncogene; 1995 Dec; 11(12):2599-607. PubMed ID: 8545117
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.
    Ferone D; van Hagen PM; van Koetsveld PM; Zuijderwijk J; Mooy DM; Lichtenauer-Kaligis EG; Colao A; Bogers AJ; Lombardi G; Lamberts SW; Hofland LJ
    Endocrinology; 1999 Jan; 140(1):373-80. PubMed ID: 9886848
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Distribution, targeting, and internalization of the sst4 somatostatin receptor in rat brain.
    Schreff M; Schulz S; Händel M; Keilhoff G; Braun H; Pereira G; Klutzny M; Schmidt H; Wolf G; Höllt V
    J Neurosci; 2000 May; 20(10):3785-97. PubMed ID: 10804219
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors.
    Binderup T; Knigge U; Mellon Mogensen A; Palnaes Hansen C; Kjaer A
    Neuroendocrinology; 2008; 87(4):223-32. PubMed ID: 18196892
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell lines.
    Dizeyi N; Konrad L; Bjartell A; Wu H; Gadaleanu V; Hansson J; Helboe L; Abrahamsson PA
    Urol Oncol; 2002; 7(3):91-8. PubMed ID: 12474541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
    Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
    Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors.
    Notas G; Kolios G; Mastrodimou N; Kampa M; Vasilaki A; Xidakis C; Castanas E; Thermos K; Kouroumalis E
    J Hepatol; 2004 May; 40(5):792-8. PubMed ID: 15094227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.